Xiaoling Zhong
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 6
- DNA Repair Mechanisms 4
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 5
- Co-authors
- Frederick J. Rescorla (5 shared papers)Teresa A. Zimmers (10 shared papers)Ahmad R. Safa (4 shared papers)Lan Tan (17 shared papers)Jin‐Tai Yu (14 shared papers)John Gordon (2 shared papers)Armaghan Emami (1 shared paper)Soo-Jung Park (1 shared paper)
- Journals
- Annals of Translational Medicine (3 papers)Medicine (2 papers)Cancer Research (2 papers)Journal of Cachexia Sarcopenia and Muscle (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xiaoling Zhong
77 papers receiving 1.9k citations
Xiaoling Zhong's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 567
- Cancer Research 288
- Pathology and Forensic Medicine 203
- Immunology 236
- Neurology 151
Countries citing papers authored by Xiaoling Zhong
This map shows the geographic impact of Xiaoling Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Zhong more than expected).
Fields of papers citing papers by Xiaoling Zhong
This network shows the impact of papers produced by Xiaoling Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Zhong. The network helps show where Xiaoling Zhong may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Zhong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer Hit paper breakdown → | 2016 | 413 |
| 2 | 2004 | 173 | |
| 3 | 2011 | 145 | |
| 4 | 2008 | 124 | |
| 5 | 2020 | 74 | |
| 6 | 2015 | 64 | |
| 7 | 2008 | 57 | |
| 8 | 2022 | 55 | |
| 9 | 2019 | 54 | |
| 10 | 2011 | 50 | |
| 11 | 2012 | 46 | |
| 12 | 2014 | 42 | |
| 13 | 2004 | 35 | |
| 14 | 2019 | 35 | |
| 15 | 2014 | 32 | |
| 16 | 2011 | 31 | |
| 17 | 2003 | 29 | |
| 18 | 2023 | 26 | |
| 19 | 2011 | 26 | |
| 20 | 2023 | 25 |
About Xiaoling Zhong
Xiaoling Zhong is a scholar working on Molecular Biology, Cancer Research, Neurology, Oncology and Physiology, having authored 79 papers that have together received 2.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Genetic factors in colorectal cancer (7 papers), Circular RNAs in diseases (6 papers), Nutrition and Health in Aging (5 papers), Cancer-related molecular mechanisms research (5 papers), DNA Repair Mechanisms (4 papers), Neuroblastoma Research and Treatments (4 papers) and Neuroscience and Neural Engineering (4 papers). The work is most often cited by research in Oncology (567 citations), Cancer Research (288 citations), Pathology and Forensic Medicine (203 citations), Immunology (236 citations) and Neurology (151 citations). Xiaoling Zhong has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Frederick J. Rescorla, Teresa A. Zimmers, Ahmad R. Safa, Lan Tan, Jin‐Tai Yu, John Gordon, Armaghan Emami, Soo-Jung Park, Qun Zhang and Tanios Bekaii‐Saab. Their work appears in journals such as Annals of Translational Medicine, Medicine, Cancer Research, Journal of Cachexia Sarcopenia and Muscle and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.